Clinical Pathology: Hematology & Coagulation

376) A 29-year-old man presents to his physician for partner screening. The complete blood cell count (CBC) and ferritin level are shown in the table. The figure shows the hemoglobin fractions identified on high-performance liquid chromatography (HPLC). Which one of the following is the most likely diagnosis?
Patient Reference Range Units
WBC 8.4 3.04–9.06 ×109/L
RBC 5.96 4.3–5.6 ×1012/L
Hemoglobin 15.6 13.3–16.2 g/dL
Hematocrit 44.9 38.8–46.4 %
MCV 75.3 79.0–93.3 fL
MCH 26.2 26.7–31.9 pg
MCHC 34.7 32.3–35.9 g/dL
RDW 13.8 <14 %
PLT 175 165–415 ×109/L
Ferritin 129 29–248 ng/mL

• There are four α-globin genes (two on each chromosome) with two α-globin genes in cis on each chromosome (α2, α1). α-Thalassemias are most commonly caused by deletion of one or more α-globin genes.

• α-Thalassemia trait can be inherited as one α-globin gene deletion (-α/αα), two α- globin gene deletions in trans (-α/-α), or two α-globin genes deleted in cis (--/αα).

• One α-globin gene deletion --α/αα) is usually clinically and hematologically silent but can show mild microcytosis and hypochromia.

• α-Thalassemia trait caused by two gene deletions in cis or trans (--/αα or --α/-α, respectively) is hematologically mild; there may be a very mild anemia, but the hemoglobin can have overlap with the reference range; and an elevated red blood cell count (RBC), a reduced mean corpuscular volume (MCV), and a reduced mean corpuscular hemoglobin (MCH) are generally present.

• A presumptive diagnosis of α-thalassemia trait can be made when there are red cell indices suggestive of thalassemia (i.e., elevated RBC; low MCV and MCH), a normal hemoglobin A2 and F, and normal iron studies.



 
* = Required 
* Note Title
* Note